# Verify tickers, programs, and catalyst dates Canonical URL: https://biopharmsignal.com/use-cases/biotech-newsletter-writers/verify-tickers-programs-and-catalyst-dates Role: [Biotech Newsletter Writers](https://biopharmsignal.com/use-cases/biotech-newsletter-writers.md) Category: Editorial operations Last updated: 2026-07-26 Normalize the entities readers use to find and follow a story. ## The Situation A writer must publish quickly while company names, program codes, licensing ownership, and event timing may differ across sources. ### Best Fit Independent writers, newsletter teams, financial media creators, podcasters, and editors covering biotechnology and pharmaceutical companies. ## The Challenge Normalize the entities readers use to find and follow a story. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. ## How To Think About The Task A writer must publish quickly while company names, program codes, licensing ownership, and event timing may differ across sources. For newsletter writers, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again. Normalize the entities readers use to find and follow a story. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later. ### Start with the decision this work must support “Verify tickers, programs, and catalyst dates” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful. ### Build a source-linked change record The core monitoring set for this workflow includes current company and ticker, program name and code, asset ownership, primary timing source, date confidence. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot. ### Turn monitoring into an owned output A pre-publication entity and timing checklist with normalized names, ownership, source links, and confidence labels. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. The publication reduces avoidable factual errors and creates consistent entities readers can follow across stories. ## Illustrative Example ### Illustrative workflow: verify tickers, programs, and catalyst dates Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change. Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event. ### Questions To Answer Before Making A Decision - What has changed in current company and ticker, and why does it matter? - What has changed in program name and code, and why does it matter? - What has changed in asset ownership, and why does it matter? - What has changed in primary timing source, and why does it matter? - What has changed in date confidence, and why does it matter? ## A Repeatable Workflow 1. Define the specific decision or research question behind “verify tickers, programs, and catalyst dates.” 2. Set the monitored scope around current company and ticker and program name and code. 3. Collect source-linked updates for asset ownership and record what changed from the prior state. 4. Review primary timing source together with date confidence before drawing a conclusion. 5. Produce the required output, assign follow-up ownership, and set the next review point. ## Signals To Keep Visible - Current company and ticker - Program name and code - Asset ownership - Primary timing source - Date confidence ## Common Mistakes - Starting the monitoring process without a defined decision question - Recording the latest state without preserving its source or previous state - Ending with collected information but no owner, conclusion, or next review ## Deliverable A pre-publication entity and timing checklist with normalized names, ownership, source links, and confidence labels. ## Practical Outcome The publication reduces avoidable factual errors and creates consistent entities readers can follow across stories. ## Where BioPharmSignal Fits Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep relevant tickers and keywords visible. The workflow still requires independent research and judgment. ## Frequently Asked Questions ### Who is this workflow for? It is designed for biotech newsletter writers and adjacent biotech research users who need a repeatable, source-linked way to complete this task. ### What should this workflow produce? A pre-publication entity and timing checklist with normalized names, ownership, source links, and confidence labels. ### What is the practical benefit? The publication reduces avoidable factual errors and creates consistent entities readers can follow across stories. ## Related Workflows - [How Biotech Writers Build a Daily News Briefing](https://biopharmsignal.com/use-cases/biotech-newsletter-writers/daily-biotech-newsletter-briefing.md) - [How Newsletter Writers Build a Weekly Biotech Catalyst Roundup](https://biopharmsignal.com/use-cases/biotech-newsletter-writers/weekly-biotech-catalyst-roundup.md) - [How Biotech Writers Organize Medical Conference Coverage](https://biopharmsignal.com/use-cases/biotech-newsletter-writers/medical-conference-coverage-workflow.md) Format note: This is an illustrative workflow guide, not a named customer testimonial or a claim of investment performance.